As part of its Community Case Forum series, key opinion leaders and participants discuss the development of immunotherapy for patients with advanced endometrial cancer.
Brexu-cel Results in High Rates of CNS Remission in R/R B-Cell ALL
Liso-cel Improves Responses, Survival in High-Risk MCL
Frontline Olaparib Plus Abiraterone Provides Consistent Clinical Benefit in HRR-Mutated mCRPC
Assessing Subsequent Therapies in mHSPC Confirms OS Benefit From Darolutamide
2 Commerce Drive Cranbury, NJ 08512